Targeting DNA Methylation in Podocytes to Overcome Chronic Kidney Disease
- PMID: 37271519
- DOI: 10.2302/kjm.2022-0017-IR
Targeting DNA Methylation in Podocytes to Overcome Chronic Kidney Disease
Abstract
The number of patients with chronic kidney disease (CKD) is on the rise worldwide, and there is urgent need for the development of effective plans against the increasing incidence of CKD. Podocytes, glomerular epithelial cells, are an integral part of the primary filtration unit of the kidney and form a slit membrane as a barrier to prevent proteinuria. The role of podocytes in the pathogenesis and progression of CKD is now recognized. Podocyte function depends on a specialized morphology with the arranged foot processes, which is directly related to their function. Epigenetic changes responsible for the regulation of gene expression related to podocyte morphology have been shown to be important in the pathogenesis of CKD. Although epigenetic mechanisms include DNA methylation, histone modifications, and RNA-based regulation, we have focused on DNA methylation changes because they are more stable than other epigenetic modifications. This review summarizes recent literature about the role of altered DNA methylation in the kidney, especially in glomerular podocytes, focusing on transcription factors and DNA damage responses that are closely associated with the formation of DNA methylation changes.
Keywords: DNA damage repair; DNA methylation; epigenetic changes; podocytes.
Similar articles
-
BDNF: mRNA expression in urine cells of patients with chronic kidney disease and its role in kidney function.J Cell Mol Med. 2018 Nov;22(11):5265-5277. doi: 10.1111/jcmm.13762. Epub 2018 Aug 21. J Cell Mol Med. 2018. PMID: 30133147 Free PMC article.
-
Significance of podocyte DNA damage and glomerular DNA methylation in CKD patients with proteinuria.Hypertens Res. 2023 Apr;46(4):1000-1008. doi: 10.1038/s41440-023-01169-2. Epub 2023 Jan 17. Hypertens Res. 2023. PMID: 36646881
-
Alteration of histone H3K4 methylation in glomerular podocytes associated with proteinuria in patients with membranous nephropathy.BMC Nephrol. 2016 Nov 17;17(1):179. doi: 10.1186/s12882-016-0390-8. BMC Nephrol. 2016. PMID: 27855638 Free PMC article.
-
Unraveling the epigenetic landscape of glomerular cells in kidney disease.J Mol Med (Berl). 2021 Jun;99(6):785-803. doi: 10.1007/s00109-021-02066-2. Epub 2021 Mar 24. J Mol Med (Berl). 2021. PMID: 33763722 Review.
-
Targeting podocyte-associated diseases.Adv Drug Deliv Rev. 2010 Nov 30;62(14):1325-36. doi: 10.1016/j.addr.2010.08.012. Epub 2010 Sep 7. Adv Drug Deliv Rev. 2010. PMID: 20828590 Review.
Cited by
-
Epigenetic DNA Methylation and Protein Homocysteinylation: Key Players in Hypertensive Renovascular Damage.Int J Mol Sci. 2024 Oct 29;25(21):11599. doi: 10.3390/ijms252111599. Int J Mol Sci. 2024. PMID: 39519150 Free PMC article. Review.
-
Sulforaphane regulates AngII-induced podocyte oxidative stress injury through the Nrf2-Keap1/ho-1/ROS pathway.Ren Fail. 2024 Dec;46(2):2416937. doi: 10.1080/0886022X.2024.2416937. Epub 2024 Oct 17. Ren Fail. 2024. PMID: 39417305 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical